TV News LIES

Thursday, Dec 18th

Last update05:17:29 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Air Pollution Exposure in Pregnancy Linked to Autism in Study

Autism and air pollutionWomen who are exposed to high levels of air pollution during their third trimester of pregnancy...

Oregon GMO labeling proponents concede defeat

Oregon defeats GO labelingProponents of an Oregon ballot measure requiring labels on genetically modified foods conceded defeat Thursday after...

Justices reject Arizona bid over abortion drugs

Planned parenthoodThe Supreme Court is refusing to allow Arizona to enforce stringent restrictions on medical abortions while...

That Takeout Coffee Cup May Be Messing With Your Hormones

BPA free plastic also toxicMost people know that some plastics additives, such as bisphenol A (BPA), may be harmful to...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!